ADAM GEDNEY: Open Payments
NPI 1326109018 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 36 payments from 13 companies in 2025. Trend: 2023 $759 · 2024 $814 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $153 |
| AstraZeneca Pharmaceuticals LP | 9 | $138 |
| Phathom Pharmaceuticals, Inc. | 2 | $132 |
| ABBVIE INC. | 6 | $108 |
| Abbott Laboratories | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Exact Sciences Corporation | 2 | $36 |
| Novo Nordisk Inc | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: VOQUEZNA, REPATHA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, FARXIGA, QULIPTA, UBRELVY, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
